Showing results (751-760 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|October 16, 2015
microRNA-622 acts as a tumor suppressor in hepatocellular carcinomaWei-Hua Song, Xiao-Jun Feng, Shao-Juan Gong, et al.Cancer Biology & Therapy|October 16, 2015
Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cellsYongqiang Chen, Elizabeth S Henson, Wenyan Xiao, et al.Cancer Biology & Therapy|September 30, 2015
Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceTimothy Webb, Jori Carter, Jane L Roberts, et al.Cancer Biology & Therapy|September 30, 2015
Hodgkin lymphoma cell lines bind to platelets. Incubation with platelets induces CD15 and P-selectin dependent adhesion of the cell lines to Human Umbilical Vein Endothelial cells (HUVEC)Ofra Malka Ohana, Janet Ozer, Isebrand Prinsloo, et al.Cancer Biology & Therapy|September 19, 2015
Bruton's tyrosine kinase is a potential therapeutic target in prostate cancerLeila Kokabee, Xianhui Wang, Christopher J Sevinsky, et al.Cancer Biology & Therapy|January 9, 2015
Enzalutamide for treatment of CRPC: rationale for sequencing and potential clinical biomarker for resistanceSarah E Lochrin, William D Figg, Stephen P FinnCancer Biology & Therapy|January 15, 2015
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancerSatsuki Mashiko, Kazuyuki Kitatani, Masafumi Toyoshima, et al.Cancer Biology & Therapy|January 15, 2015
Beyond the histone tale: HP1α deregulation in breast cancer epigeneticsJohan Vad-Nielsen, Anders Lade NielsenCancer Biology & Therapy|July 16, 2014
Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLCSusan Heavey, Peter Godwin, Anne-Marie Baird, et al.Cancer Biology & Therapy|July 22, 2014
Potential novel role of bevacizumab in glioblastoma and cervical cancerAndrew K L Goey, William D FiggPageof 387